[3-(aminomethyl)-3-methylpyrrolidin-1-yl]-(3-pyridin-2-yl-1,2-oxazol-5-yl)methanone;dihydrochloride
C15H20Cl2N4O2 — CID 120806988
Data last refreshed: (MolForge compound catalog, from PubChem)
About [3-(aminomethyl)-3-methylpyrrolidin-1-yl]-(3-pyridin-2-yl-1,2-oxazol-5-yl)methanone;dihydrochloride
[3-(aminomethyl)-3-methylpyrrolidin-1-yl]-(3-pyridin-2-yl-1,2-oxazol-5-yl)methanone;dihydrochloride (PubChem CID 120806988) has the molecular formula C15H20Cl2N4O2 and a molecular weight of 359.26 g/mol. Its IUPAC name is [3-(aminomethyl)-3-methylpyrrolidin-1-yl]-(3-pyridin-2-yl-1,2-oxazol-5-yl)methanone;dihydrochloride.
Molecular Properties
| Compound Name | [3-(aminomethyl)-3-methylpyrrolidin-1-yl]-(3-pyridin-2-yl-1,2-oxazol-5-yl)methanone;dihydrochloride |
|---|---|
| PubChem CID | 120806988 |
| Molecular Formula | C15H20Cl2N4O2 |
| Molecular Weight | 359.26 g/mol |
| Exact Mass | 358.10 |
| IUPAC Name | [3-(aminomethyl)-3-methylpyrrolidin-1-yl]-(3-pyridin-2-yl-1,2-oxazol-5-yl)methanone;dihydrochloride |
| SMILES | CC1(CN)CCN(C(=O)c2cc(-c3ccccn3)no2)C1.Cl.Cl |
| InChI | InChI=1S/C15H18N4O2.2ClH/c1-15(9-16)5-7-19(10-15)14(20)13-8-12(18-21-13)11-4-2-3-6-17-11;;/h2-4,6,8H,5,7,9-10,16H2,1H3;2*1H |
| InChIKey | FFLSIYCAVUUGEX-UHFFFAOYSA-N |
| XLogP | 2.39 |
| TPSA | 85.25 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 359.26 |
| LogP ≤ 5 | 2.39 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 120806988 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.